Literature DB >> 31938392

Vasculogenic mimicry and expression of slug and vimentin correlate with metastasis and prognosis in non-small cell lung cancer.

Hong Song1,2,3, Hongfei Ci1,2, Jing Xu1,2, Zhouyi Xu1,2, Yu Zhang1,2, Yichao Wang1,2, Shiwu Wu1,2, Yisheng Tao1,2.   

Abstract

Background: Non-small cell lung cancer (NSCLC) has been the leading cause of cancer death in recent years, its morbidity and mortality were increasing yearly. The presence of vasculogenic mimicry (VM) is associated with a high tumor grade, short survival, invasion, and metastasis. Slug is a key regulating factor in the process of EMT. Vimentin is one of the cytoskeleton proteins that plays an important role in EMT. However, associations among VM, Slug and vimentin and their clinicopathologic significance in NSCLC are unclear. In this study, we analyzed associations among VM, Slug and vimentin in NSCLC, and their respective associations with clinicopathologic characteristics and survival in NSCLC.
Methods: Positive expression of VM, Slug and vimentin in 198 whole NSCLC tissue samples were detected by immunohistochemical staining. Patients' clinical data were also collected.
Results: Levels of VM, Slug and vimentin were significantly higher in NSCLC tissues than in normal lung tissues. Levels of VM, Slug and vimentin were positively associated with tumor grade, distant metastasis (DM), lymph node metastasis (LNM), and tumor-node metastasis (TNM) stage, and inversely with patients overall survival time (OST). In multivariate analysis, high expression of VM, Slug, vimentin, and tumor grade, DM, LNM, TNM stage, were potential to be independent prognostic factors for OST in patients with NSCLC.
Conclusion: VM, Slug and vimentin affect NSCLC evolution; and the combined detection of VM, Slug and vimentin are valuable factors for metastasis and prognosis in NSCLC patients. IJCEP
Copyright © 2018.

Entities:  

Keywords:  Non-small cell lung cancer; VM; prognosis; slug; vimentin

Year:  2018        PMID: 31938392      PMCID: PMC6958269     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  4 in total

1.  Protocadherin alpha 3 inhibits lung squamous cell carcinoma metastasis and epithelial-mesenchymal transition.

Authors:  Yu Tao; Liu Fei; Liu Chang; Liu Yongyu; Jia Jianhui; Liu Yanan; Ren Yi
Journal:  Genes Genomics       Date:  2021-06-04       Impact factor: 1.839

2.  Inhibition of Vasculogenic Mimicry and Angiogenesis by an Anti-EGFR IgG1-Human Endostatin-P125A Fusion Protein Reduces Triple Negative Breast Cancer Metastases.

Authors:  Seung-Uon Shin; Hyun-Mi Cho; Rathin Das; Hava Gil-Henn; Sundaram Ramakrishnan; Ahmed Al Bayati; Stephen F Carroll; Yu Zhang; Ankita P Sankar; Christian Elledge; Augustin Pimentel; Marzenna Blonska; Joseph D Rosenblatt
Journal:  Cells       Date:  2021-10-27       Impact factor: 6.600

3.  Down-regulating NEAT1 inhibited the viability and vasculogenic mimicry formation of sinonasal squamous cell carcinoma cells via miR-195-5p/VEGFA axis.

Authors:  Honglue Lu; Fei Kang
Journal:  Biosci Rep       Date:  2020-11-27       Impact factor: 3.840

Review 4.  Autophagy Process in Trophoblast Cells Invasion and Differentiation: Similitude and Differences With Cancer Cells.

Authors:  Lorena Carvajal; Jaime Gutiérrez; Eugenia Morselli; Andrea Leiva
Journal:  Front Oncol       Date:  2021-04-15       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.